The research shows conclusively that the influenza vaccine is effective at protecting people from sickness. But unfortunately, not every person is eligible to receive the potentially life-saving vaccination.
It’s not too late to get a flu vaccine, and now there’s a new one to consider. The first seasonal flu vaccine containing an adjuvant, Fluad, received accelerated approval from the US Food and Drug Administration (FDA) for adults age 65 and older.
While many people get their flu vaccine on a yearly basis there are some who are still hesitant while others simply refuse. New modes of delivery and new guidelines aim to help answer some lingering questions patients may have.
The flu season of 2014 was one of the worst in recent memory which brought up questions about the flu vaccine which patients received in order to prevent contracting the disease. The answers for those questions could provide better results in years to come.
October has been pinpointed as the start of flu season in the United States. So if prevention of the contagious illness isn't enough to convince patients to get their influenza vaccine, a new analysis involving stroke risk just might.